Tải bản đầy đủ - 0 (trang)
Một số yếu tố nguy cơ.

Một số yếu tố nguy cơ.

Tải bản đầy đủ - 0trang



Alberti, K., et al., Harmonizing the metabolic syndrome: a joint interim

statement of the international diabetes federation task force on

epidemiology and prevention; national heart, lung, and blood institute;

American heart association; world heart federation; international

atherosclerosis society; and international association for the study of

obesity. Circulation, 2009. 120(16): p. 1640-1645.








thrombosis, and vascular biology, 2008. 28(4): p. 629-636.


Ford, E.S., W.H. Giles, and W.H. Dietz, Prevalence of the metabolic

syndrome among US adults: findings from the third National Health and

Nutrition Examination Survey. Jama, 2002. 287(3): p. 356-359.


Aguilar, M., et al., Prevalence of the metabolic syndrome in the United

States, 2003-2012. Jama, 2015. 313(19): p. 1973-1974.


Pan, W.-H., W.-T. Yeh, and L.-C. Weng, Epidemiology of metabolic

syndrome in Asia. Asia Pacific journal of clinical nutrition, 2008. 17(S1):

p. 37-42.


Van Tran, H., M. T Truong, and T. Nguyen, Prevalence of Metabolic

Syndrome in Adults in Khanh Hoa, Vietnam. Vol. 1. 2004. 95-100.


Binh, T., et al., Metabolic syndrome among a middle-aged population in

the Red River Delta region of Vietnam. Vol. 14. 2014. 77.


Chan, J.C., et al., Diabetes in Asia: epidemiology, risk factors, and

pathophysiology. Jama, 2009. 301(20): p. 2129-2140.


Lin, C.-C., et al., The relation of metabolic syndrome according to five

definitions to cardiovascular risk factors-a population-based study.

BMC Public Health, 2009. 9(1): p. 484.

10. Crepaldi, G. and S. Maggi, The metabolic syndrome: a historical

context. Diabetes voice, 2006. 51: p. 8-10.

11. Sarafidis, P.A. and P.M. Nilsson, The metabolic syndrome: a glance at

its history. Journal of hypertension, 2006. 24(4): p. 621-626.

12. Expert Panel on Detection, E., Executive summary of the Third Report of

the National Cholesterol Education Program (NCEP) expert panel on

detection, evaluation, and treatment of high blood cholesterol in adults

(Adult Treatment Panel III). Jama, 2001. 285(19): p. 2486.

13. Bravata, D.M., et al., Two measures of insulin sensitivity provided

similar information in a US population. Journal of clinical epidemiology,

2004. 57(11): p. 1214-1217.

14. Carey, D.G., et al., Abdominal fat and insulin resistance in normal and

overweight women: direct measurements reveal a strong relationship in

subjects at both low and high risk of NIDDM. Diabetes, 1996. 45(5): p.


15. Bacon, B., Harrison's Principles of Internal Medicine. 19e. 2015, New

York, NY: McGraw-Hill Education.

16. Flegal, K.M., et al., Trends in obesity among adults in the United States,

2005 to 2014. Jama, 2016. 315(21): p. 2284-2291.

17. Stefan, N., et al., Identification and characterization of metabolically

benign obesity in humans. Archives of internal medicine, 2008. 168(15):

p. 1609-1616.

18. Franỗa, S.L., S.S. Lima, and J.R.D.S. Vieira, Metabolic syndrome and

associated factors in adults of the Amazon region. PloS one, 2016.

11(12): p. e0167320.

19. Zhao, Y., et al., Prevalence and determinants of metabolic syndrome

among adults in a rural area of Northwest China. PloS one, 2014. 9(3):

p. e91578.

20. Chan, J.M., et al., Obesity, fat distribution, and weight gain as risk factors

for clinical diabetes in men. Diabetes care, 1994. 17(9): p. 961-969.

21. Stamler, J., Epidemiologic findings on body mass and blood pressure in

adults. Annals of epidemiology, 1991. 1(4): p. 347-362.

22. Force, U.P.S.T., Screening for obesity in adults: recommendations and

rationale. Annals of internal medicine, 2003. 139(11): p. 930.

23. Kannel, W. and D. McGee, Diabetes and glucose tolerance as risk

factors for cardiovascular disease: the Framingham study. Diabetes

care, 1979. 2(2): p. 120-126.

24. Reeder, B.A., et al., The association of cardiovascular disease risk

factors with abdominal obesity in Canada. Canadian Heart Health

Surveys Research Group. CMAJ: Canadian Medical Association journal

journal de l'Association medicale canadienne, 1997. 157: p. S39-45.

25. Kenchaiah, S., et al., Obesity and the risk of heart failure. New England

Journal of Medicine, 2002. 347(5): p. 305-313.

26. Tokunaga, K., et al., A novel technique for the determination of body fat

by computed tomography. International journal of obesity, 1983. 7(5): p.


27. Fujioka, S., et al., Contribution of intra-abdominal fat accumulation to

the impairment of glucose and lipid metabolism in human obesity.

Metabolism, 1987. 36(1): p. 54-59.

28. Rexrode, K.M., et al., Abdominal adiposity and coronary heart disease

in women. Jama, 1998. 280(21): p. 1843-1848.

29. Després, J.-P., et al., Estimation of deep abdominal adipose-tissue

accumulation from simple anthropometric measurements in men. The

American journal of clinical nutrition, 1991. 54(3): p. 471-477.

30. Ferland, M., et al., Assessment of adipose tissue distribution by

computed axial tomography in obese women: association with body

density and anthropometric measurements. British Journal of Nutrition,

1989. 61(2): p. 139-148.

31. Dalton, M., et al., Waist circumference, waist–hip ratio and body mass

index and their correlation with cardiovascular disease risk factors in

Australian adults. Journal of internal medicine, 2003. 254(6): p. 555-563.

32. Kershaw, E.E. and J.S. Flier, Adipose tissue as an endocrine organ. The

Journal of Clinical Endocrinology & Metabolism, 2004. 89(6): p. 2548-2556.

33. Tilg, H. and A.R. Moschen, Role of adiponectin and PBEF/visfatin as

regulators of inflammation: involvement in obesity-associated diseases.

Clinical science, 2008. 114(4): p. 275-288.

34. Randle, P., P. Garland, and C. HALr, s & EA NEWSHOLME. 1963. The

glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic

disturbances of diabetes mellitus. Lancet i: p. 785-789.

35. Weisberg, S.P., et al., Obesity is associated with macrophage

accumulation in adipose tissue. Journal of clinical investigation, 2003.

112(12): p. 1796.

36. Ginsberg, H.N., Y.-L. Zhang, and A. Hernandez-Ono, Regulation of

plasma triglycerides in insulin resistance and diabetes. Archives of

medical research, 2005. 36(3): p. 232-240.

37. Alberti, K.G.M.M. and P.f. Zimmet, Definition, diagnosis and

classification of diabetes mellitus and its complications. Part 1:

diagnosis and classification of diabetes mellitus. Provisional report of a

WHO consultation. Diabetic medicine, 1998. 15(7): p. 539-553.

38. Balkau, B., Comment on the provisional report from the WHO

consultation. European Group for the Study of Insulin Resistance

(EGIR). Diabet Med, 1999. 16: p. 442-443.

39. Expert Panel on, D., Evaluation, and A. and Treatment of High Blood

Cholesterol in, Executive summary of the third report of the national

cholesterol education program (ncep) expert panel on detection,

evaluation, and treatment of high blood cholesterol in adults (adult

treatment panel iii). JAMA, 2001. 285(19): p. 2486-2497.

40. Bloomgarden, Z.T., American Association of Clinical Endocrinologists

(AACE) consensus conference on the insulin resistance syndrome: 25–26

August 2002, Washington, DC. Diabetes Care, 2003. 26(3): p. 933-939.

41. Alberti, K.G.M.M., P. Zimmet, and J. Shaw, Metabolic syndrome—a

new world‐wide definition. A consensus statement from the international

diabetes federation. Diabetic medicine, 2006. 23(5): p. 469-480.

42. Binh, T.Q., P.T. Phuong, and B.T. Nhung, Metabolic syndrome among a

middle-aged population in the Red River Delta region of Vietnam. BMC

endocrine disorders, 2014. 14(1): p. 77.

43. Cornier, M.-A., et al., The metabolic syndrome. Endocrine reviews,

2008. 29(7): p. 777-822.

44. Kvist, H., et al., Total and visceral adipose-tissue volumes derived from

measurements with computed tomography in adult men and women:

predictive equations. The American journal of clinical nutrition, 1988.

48(6): p. 1351-1361.

45. Pradhan, A.D., Sex Differences in the Metabolic Syndrome: Implications

for Cardiovascular Health in Women. Clinical Chemistry, 2014. 60(1): p.


46. Duc Son LNT, K.D., Hung NT, Sakai T, Yamamoto S: The metabolic,

s.p.a.r.f.i.t.u.p.o.H. Chi, and Minh City. Diabet Res Clin Pract 2005.

47. Ford, E.S., Prevalence of the metabolic syndrome defined by the

International Diabetes Federation among adults in the US. Diabetes

care, 2005. 28(11): p. 2745-2749.

48. Lao, X.Q., et al., Dramatic escalation in metabolic syndrome and

cardiovascular risk in a Chinese population experiencing rapid

economic development. BMC Public Health, 2014. 14(1): p. 983.

49. Sy, R.G., et al., Socio-demographic factors and the prevalence of

metabolic syndrome among Filipinos from the LIFECARE cohort.

Journal of atherosclerosis and thrombosis, 2014. 21(Supplement1): p.


50. Van Tran, H., M. Truong, and T. Nguyen, Prevalence of metabolic

syndrome in adults in Khanh Hoa, Viet Nam. J Geriatr Cardiol, 2004.

1(2): p. 95-100.

51. Trương, T.M. and T.L. Nguyễn, Tình trạng kháng Insulin và hội chứng

rối loạn chuyển hóa ở người trưởng thành 40-59 tuổi thừa cân béo phì

tại một phường nội thành Hà Nội (Insulin resistance and metabolic

syndrome in overweight/obesity adults 40-59 years at a ward, Hanoi).

52. Palaniappan, L.P., et al., Asian Americans have greater prevalence of

metabolic syndrome despite lower body mass index. International journal

of obesity (2005), 2011. 35(3): p. 393.

53. Wamala, S.P., et al., Education and the metabolic syndrome in women.

Diabetes care, 1999. 22(12).

54. Silventoinen, K., et al., Educational inequalities in the metabolic

syndrome and coronary heart disease among middle-aged men and

women. International Journal of Epidemiology, 2005. 34(2): p. 327-334.

55. Brunner, E., et al., Social inequality in coronary risk: central obesity and

the metabolic syndrome. Evidence from the Whitehall II study.

Diabetologia, 1997. 40(11): p. 1341-1349.

56. Park, M.J., et al., A cross-sectional study of socioeconomic status and

the metabolic syndrome in Korean adults. Annals of epidemiology, 2007.

17(4): p. 320-326.

57. Hoffmann, I.S. and L.X. Cubeddu, Salt and the metabolic syndrome.

Nutrition, Metabolism and Cardiovascular Diseases, 2009. 19(2): p. 123128.

58. Sakurai, Y., et al., Relation of total and beverage-specific alcohol intake

to body mass index and waist-to-hip ratio: a study of self-defense

officials in Japan. European journal of epidemiology, 1997. 13(8): p.


59. General, S., J. Wright, and D.H. Speaker, Nicotine addiction. A report of

the Surgeon General. US Dept. of Health and Human Services,

Washington DC Google Scholar, 1988.

60. Wannamethee, S.G. and A.G. Shaper, Alcohol, body weight, and weight

gain in middle-aged men. The American journal of clinical nutrition,

2003. 77(5): p. 1312-1317.

61. GOUDE, D., B. FAGERBERG, and J. HULTHE, Alcohol consumption,

the metabolic syndrome and insulin resistance in 58-year-old clinically

healthy men (AIR study). Clinical Science, 2002. 102(3): p. 345-352.

62. Lazarus, R., D. Sparrow, and S.T. Weiss, Alcohol intake and insulin

levels: the Normative Aging Study. American journal of epidemiology,

1997. 145(10): p. 909-916.

63. Rimm, E.B., et al., Moderate alcohol intake and lower risk of coronary

heart disease: meta-analysis of effects on lipids and haemostatic factors.

Bmj, 1999. 319(7224): p. 1523-1528.

64. Fan, J.-G., et al., Alcohol consumption and metabolic syndrome among

Shanghai adults: a randomized multistage stratified cluster sampling

investigation. World Journal of Gastroenterology: WJG, 2008. 14(15): p. 2418.

65. McFadden, C.B., et al., Systematic review of the effect of daily alcohol

intake on blood pressure. 2005, Oxford University Press.

66. Xin, X., et al., Effects of alcohol reduction on blood pressure: a metaanalysis of randomized controlled trials. Hypertension, 2001. 38(5): p.


67. Slagter, S.N., et al., Combined effects of smoking and alcohol on metabolic

syndrome: the LifeLines cohort study. PloS one, 2014. 9(4): p. e96406.

68. Ambrose, J.A. and R.S. Barua, The pathophysiology of cigarette

smoking and cardiovascular disease: an update. Journal of the American

college of cardiology, 2004. 43(10): p. 1731-1737.

69. Xiao, J., et al., Prevalence of metabolic syndrome and its risk factors among

rural adults in Nantong, China. Scientific reports, 2016. 6: p. 38089.

70. Oh, S.W., et al., Association between cigarette smoking and metabolic

syndrome: the Korea National Health and Nutrition Examination

Survey. Diabetes care, 2005. 28(8): p. 2064-2066.

71. Zuo, H., et al., Prevalence of metabolic syndrome and factors associated

with its components in Chinese adults. Metabolism, 2009. 58(8): p.


72. Vona, M., et al., Impact of physical training and detraining on

endothelium-dependent vasodilation in patients with recent acute

myocardial infarction. American heart journal, 2004. 147(6): p. 1039-1046.

73. Boulé, N.G., et al., Effects of exercise on glycemic control and body

mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical

trials. Jama, 2001. 286(10): p. 1218-1227.

74. Ross, R., et al., Reduction in obesity and related comorbid conditions

after diet-induced weight loss or exercise-induced weight loss in men: a

randomized, controlled trial. Annals of internal medicine, 2000. 133(2):

p. 92-103.

75. Stensvold, D., et al., Strength training versus aerobic interval training to

modify risk factors of metabolic syndrome. Journal of applied

physiology, 2010. 108(4): p. 804-810.

76. Dunstan, D.W., et al., Effects of a short-term circuit weight training

program on glycaemic control in NIDDM. Diabetes research and clinical

practice, 1998. 40(1): p. 53-61.

77. Durstine, J.L., et al., Lipids, lipoproteins, and exercise. Journal of

Cardiopulmonary Rehabilitation and Prevention, 2002. 22(6): p. 385-398.

78. Moholdt, T.T., et al., Aerobic interval training versus continuous

moderate exercise after coronary artery bypass surgery: a randomized

study of cardiovascular effects and quality of life. American heart

journal, 2009. 158(6): p. 1031-1037.

79. Sigal, R.J., et al., Effects of aerobic training, resistance training, or both

on glycemic control in type 2 diabetes: a randomized trial. Annals of

internal medicine, 2007. 147(6): p. 357-369.

80. Kyu, H.H., et al., Physical activity and risk of breast cancer, colon

cancer, diabetes, ischemic heart disease, and ischemic stroke events:

systematic review and dose-response meta-analysis for the Global

Burden of Disease Study 2013. bmj, 2016. 354: p. i3857.

81. Albarwani D Phil, S., et al., Effects of overweight and leisure-time

activities on aerobic fitness in urban and rural adolescents. Metabolic

syndrome and related disorders, 2009. 7(4): p. 369-374.

82. Vandelanotte, C., et al., Associations of leisure-time internet and

computer use with overweight and obesity, physical activity and

sedentary behaviors: cross-sectional study. Journal of medical Internet

research, 2009. 11(3).

83. Gami, A.S., et al., Metabolic syndrome and risk of incident

cardiovascular events and death: a systematic review and meta-analysis

of longitudinal studies. Journal of the American College of Cardiology,

2007. 49(4): p. 403-414.

84. Mottillo, S., et al., The metabolic syndrome and cardiovascular risk: a

systematic review and meta-analysis. Journal of the American College of

Cardiology, 2010. 56(14): p. 1113-1132.

85. Lakka, H.-M., et al., The metabolic syndrome and total and

cardiovascular disease mortality in middle-aged men. Jama, 2002.

288(21): p. 2709-2716.

86. Sattar, N., et al., Metabolic syndrome with and without C-reactive

protein as a predictor of coronary heart disease and diabetes in the West

of Scotland Coronary Prevention Study. Circulation, 2003. 108(4): p.


87. Hong, Y., et al., Metabolic syndrome, its preeminent clusters, incident

coronary heart disease and all‐cause mortality–results of prospective

analysis for the Atherosclerosis Risk in Communities study. Journal of

internal medicine, 2007. 262(1): p. 113-122.

88. Lebovitz, H.E., Type 2 diabetes: an overview. Clinical chemistry, 1999.

45(8): p. 1339-1345.

89. Grundy, S.M., Metabolic syndrome: connecting and reconciling

cardiovascular and diabetes worlds. Journal of the American College of

Cardiology, 2006. 47(6): p. 1093-1100.

90. Ford, E.S., C. Li, and N. Sattar, Metabolic syndrome and incident

diabetes. Diabetes care, 2008. 31(9): p. 1898-1904.

91. Meigs, J.B., et al., Impact of insulin resistance on risk of type 2 diabetes

and cardiovascular disease in people with metabolic syndrome. Diabetes

care, 2007. 30(5): p. 1219-1225.

92. de Vegt, F., et al., Relation of impaired fasting and postload glucose with

incident type 2 diabetes in a Dutch population: The Hoorn Study. Jama,

2001. 285(16): p. 2109-2113.

93. Bloomgarden, Z.T., Second world congress on the insulin resistance

syndrome. Diabetes Care, 2005. 28(7): p. 1821-1830.

94. Kim, H.J., et al., Metabolic significance of nonalcoholic fatty liver

disease in nonobese, nondiabetic adults. Archives of internal medicine,

2004. 164(19): p. 2169-2175.

95. Hamaguchi, M., et al., The metabolic syndrome as a predictor of

nonalcoholic fatty liver disease. Annals of internal medicine, 2005.

143(10): p. 722.

96. Donnelly, K.L., et al., Sources of fatty acids stored in liver and secreted

via lipoproteins in patients with nonalcoholic fatty liver disease. Journal

of Clinical Investigation, 2005. 115(5): p. 1343.

97. Méndez‐Sánchez, N., et al., Current concepts in the pathogenesis of

nonalcoholic fatty liver disease. Liver International, 2007. 27(4): p. 423-433.

98. Masserini, B., et al., Reduced levels of adiponectin in sleep apnea syndrome.

Journal of endocrinological investigation, 2006. 29(8): p. 700-705.

99. Vgontzas, A.N., E.O. Bixler, and G.P. Chrousos, Sleep apnea is a

manifestation of the metabolic syndrome. Sleep medicine reviews, 2005.

9(3): p. 211-224.

100. Chen, R., G. Wittert, and G. Andrews, Relative androgen deficiency in

relation to obesity and metabolic status in older men. Diabetes, Obesity

and Metabolism, 2006. 8(4): p. 429-435.

Tài liệu bạn tìm kiếm đã sẵn sàng tải về

Một số yếu tố nguy cơ.

Tải bản đầy đủ ngay(0 tr)